Scimitar Equity Blog

RegMed Daily, Closing Bell, 2/9/12, well off the highs, stocks hold small gains, S&P back at 7 month high, sideways market struggles the course

Henry McCusker — Thu, 09 Feb 2012 21:13:57 +0000

End of Day, Cause and Effect EOD Commentary: Stocks held small gains in the final hour of trading Thursday, as initial enthusiasm over reports over a Greek debt deal fizzled and investors appeared unmoved following some better-than-expected economic news. Traders are watching to see if the S&P can climb above the 1,356 resistance [...]

RegMed Competitive and Market Intelligence 2/9/12, stocks edge higher, Aldagen acquired by CMXI.OB and Sanofi drops Osiris high-lighting sector

Henry McCusker — Thu, 09 Feb 2012 18:04:04 +0000

The 6 W’s: Who, what, where, when, why and what of it … Today’s Gospel: Let’s applause sector activity … Or are we … just caught-up and selling on the news …investors don’t seem … to be that hopeful about the details of today’s announcements … will be compelling as Aldagen/CMXI or the Sanofi’s [...]

Osiris (OSIR) drops after Sanofi discontinues P3 GvHD Program

Henry McCusker — Thu, 09 Feb 2012 16:24:53 +0000

OSIR down as much as 6.95% after Sanofi announced discontinuation of development of Prochymal in Graft-vs.-Host Disease (GvHD. Link to Sanofi’s Year end results release, http://sanofi.mediaroom.com/index.php?s=43&item=351; Extracted below (dropped projects) is what they buried deep in their announcement. 2 projects in P1 (SAR101099 – an urotensin II receptor antagonist evaluated in diabetes nephropathy and SAR103168 [...]

Cytomedix (OTC BB: CMXI) acquires Aldagen in stock deal

Henry McCusker — Thu, 09 Feb 2012 15:34:47 +0000

Cytomedix (OTC BB:CMXI) has acquired stem cell therapeutics firm company Aldagen in a $16M stock deal that broadens the firm’s regenerative therapies pipeline. Under the terms of the agreement, CMXI.OB issued Aldagen shareholders preferred shares valued at $16M, giving Aldagen an approximately 17.3% stake in CMXI. As part of the transaction, some Aldagen investors [...]

RegMed Daily, Pre-Open, 2/9712, futures are flat, an even or down opening expected

Henry McCusker — Thu, 09 Feb 2012 12:16:50 +0000

Good morning! Here’s what you … might need to know to start the day. To understand the gyrations in the RegMed universe’s market! It might provide food for thought … and portfolio awareness. Stock index futures pointed to a flat open on Thursday as investors looked ahead to talks to secure a new [...]

RegMed Daily, Closing Bell, 2/8/12, rebound theory, sell-off to positive to sell-off again to slightly positive

Henry McCusker — Thu, 09 Feb 2012 00:39:05 +0000

End of Day, Cause and Effect EOD Commentary: Stocks struggled to turn higher in a choppy session Wednesday, as investors continued to wait to see if the euro zone political leaders would come up with a resolution to the Greek sovereign debt crisis. Closing Bell: The NASDAQ [...]

BioMimetic Therapeutics (BMTI) introduces Augmatrix™ Biocomposite Bone Graft Product Line

Henry McCusker — Wed, 08 Feb 2012 19:01:33 +0000

During the American Academy of Orthopedic Surgeons (AAOS) meeting BMTI introduce Augmatrix™ Biocomposite Bone Graft, a new bone graft substitute product line, to surgeons and distributors. This Augmatrix product line is comprised of carbonate-apatite (calcium phosphate) and Type I collagen and is designed to be combined with bone marrow aspirate (BMA); The products are [...]

RegMed Competitive and Market Intelligence 2/8/12, a lackluster session, stocks turn lower, hoping EU leaders pony-up

Henry McCusker — Wed, 08 Feb 2012 18:29:41 +0000

The 6 W’s: Who, what, where, when, why and what of it … Today’s Gospel: Stocks are stuck in … purgatory … the market has acted very well since December and for the whole month of January with … no real pullbacks but … I think it has gotten ahead of itself … [...]

RegMed Daily, Pre-Open, 2/8712, futures signal a higher opening

Henry McCusker — Wed, 08 Feb 2012 13:15:55 +0000

Good morning! Here’s what you … might need to know to start the day. To understand the gyrations in the RegMed universe’s market! It might provide food for thought … and portfolio awareness. Stock futures traded slightly higher Wednesday on hopes that Greece will soon ink a deal clearing the way [...]

RegMed Daily, Closing Bell, 2/7/12, stocks edge higher slowly, as fear factor handcuffs risk appetite

Henry McCusker — Tue, 07 Feb 2012 21:13:24 +0000

End of Day, Cause and Effect EOD Commentary: Danger is when the retail investor … get in and the big-money buyers … start taking profits and the market turns lower. In market terms, it’s called “capitulation” — that moment when investors no longer can stand against the tide and finally join the crowd. Though [...]